Skip to content
E14: ACC 2022 - Μέρος 1ο episode artwork

Apr 13, 2022 29 min

E14: ACC 2022 - Μέρος 1ο

from CardioBeans Podcast Hosted by szafeirop

Συζητάμε τις πιο καυτές μελέτες του ACC 2022. Ένα νέο, first-in-class- φάρμακο, το mavacamten, για τη θεραπεία της υπερτροφικής μυοκαρδιοπάθειας (VALOR-HCM), τον αυστηρό περιορισμό του άλατος σε καρδιακή ανεπάρκεια (SODIUM-HF: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00369-5/fulltext), την αντιμετώπιση της ήπιας υπέρτασης κατά την εγκυμοσύνη (CHAP: https://www.nejm.org/doi/full/10.1056/NEJMoa2201295) και πρωτοποριακές θεραπείες της δυσλιπιδαιμίας (TRANSLATE-TIMI 70: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059266 και APOLLO: https://jamanetwork.com/journals/jama/article-abstract/2790912)

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

E14: ACC 2022 - Μέρος 1ο

0:00 29:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of CardioBeans Podcast?

This episode is 29 minutes long.

When was this CardioBeans Podcast episode published?

This episode was published on April 13, 2022.

Can I download this CardioBeans Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.